History, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease), Natural Product Reports, vol.108, issue.12, pp.1527-1567, 2013. ,
DOI : 10.1039/c3np70068b
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Nature Reviews Microbiology, vol.4, issue.1, pp.50-60, 2009. ,
DOI : 10.1093/molbev/msm092
Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence, Science, vol.283, issue.5403, pp.854-857, 1999. ,
DOI : 10.1126/science.283.5403.854
Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens, Cellular and Molecular Life Sciences, vol.198, issue.13, pp.2443-50, 2014. ,
DOI : 10.1007/s00018-014-1561-z
URL : https://hal.archives-ouvertes.fr/pasteur-01387237
Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation, J Clin Invest, vol.123, pp.1501-1513, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00874628
Mycobacterial toxin induces analgesia in buruli ulcer by targeting the Angiotensin pathways, Cell, vol.157, pp.1565-1576, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01117565
Histopathologic features of Mycobacterium ulcerans infection, Emerg Infect Dis, vol.9, pp.651-656, 2003. ,
Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans, J Leukoc Biol, vol.79, pp.1150-1156, 2006. ,
Infection in the Peripheral Blood of Patients with Buruli Ulcer Disease, The Journal of Infectious Diseases, vol.200, issue.11, pp.1675-84, 2009. ,
DOI : 10.1086/646615
URL : https://hal.archives-ouvertes.fr/pasteur-01402286
Combined Inflammatory and Metabolic Defects Reflected by Reduced Serum Protein Levels in Patients with Buruli Ulcer Disease, PLoS Neglected Tropical Diseases, vol.25, issue.4, p.2786, 2014. ,
DOI : 10.1371/journal.pntd.0002786.s001
URL : https://hal.archives-ouvertes.fr/pasteur-01384561
Mycolactone Diffuses from Mycobacterium ulcerans???Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid Organs, PLoS Neglected Tropical Diseases, vol.23, issue.10, p.325, 2008. ,
DOI : 10.1371/journal.pntd.0000325.g006
toxin mycolactone, The Journal of Experimental Medicine, vol.22, issue.6, pp.1395-1403, 2007. ,
DOI : 10.1016/0022-1759(94)90236-4
URL : https://hal.archives-ouvertes.fr/pasteur-01402321
Mycolactone Suppresses T Cell Responsiveness by Altering Both Early Signaling and Posttranslational Events, The Journal of Immunology, vol.184, issue.3, pp.1436-1444, 2010. ,
DOI : 10.4049/jimmunol.0902854
URL : https://hal.archives-ouvertes.fr/pasteur-00594632
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin, Cell Microbiol, vol.7, pp.1187-1196, 2005. ,
The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function, J Immunol, vol.163, pp.3928-3935, 1999. ,
Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism, The Journal of Immunology, vol.182, issue.4, pp.2194-2202, 2009. ,
DOI : 10.4049/jimmunol.0802294
The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER, PLoS Pathogens, vol.103, issue.4, p.1004061, 2014. ,
DOI : 10.1371/journal.ppat.1004061.s004
Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression, Proceedings of the National Academy of Sciences, vol.108, issue.31, pp.12833-12838, 2011. ,
DOI : 10.1073/pnas.1016496108
URL : https://hal.archives-ouvertes.fr/pasteur-00738806
Mycolactone diffuses into the peripheral blood of buruli ulcer patients implications for diagnosis and disease monitoring, PLoS Negl Trop Dis, vol.5, p.1237, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00691438
A diverted total synthesis of mycolactone analogues: an insight into buruli ulcer toxins, Chemistry, vol.17, pp.14413-14419, 2011. ,
A Ring-Closing Metathesis (RCM)-Based Approach to Mycolactones???A/B, Chemistry - A European Journal, vol.7, issue.46, pp.13017-13031, 2011. ,
DOI : 10.1002/chem.201101799
Organic Synthesis Toward Small-Molecule Probes and Drugs Special Feature: Chemistry of mycolactones, the causative toxins of Buruli ulcer, Proc Natl Acad Sci U S A, vol.108, pp.6699-702, 2011. ,
Synthetic Variants of Mycolactone Bind and Activate Wiskott-Aldrich Syndrome Proteins, J Med Chem, vol.57, pp.7382-95, 2014. ,
Structure-Activity Relationship Studies on the Macrolide Exotoxin Mycolactone of Mycobacterium ulcerans, PLoS Neglected Tropical Diseases, vol.182, issue.3, p.2143, 2013. ,
DOI : 10.1371/journal.pntd.0002143.s001
Neutrophils at work, Nature Immunology, vol.163, issue.7, pp.602-611, 2014. ,
DOI : 10.1182/blood-2012-05-431114
Effects of TLC-Ag dressings on skin inflammation, The Journal of Dermatology, vol.12, issue.6, pp.463-470, 2013. ,
DOI : 10.1111/1346-8138.12149
Skin Repair Properties of d-Limonene and Perillyl Alcohol in Murine Models, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, vol.13, issue.1, pp.29-35, 2014. ,
DOI : 10.2174/18715230113126660021
The formalin test in mice: dissociation between inflammatory and non-inflammatory pain, Pain, vol.30, issue.1, pp.103-114, 1987. ,
DOI : 10.1016/0304-3959(87)90088-1
Lipids of Pathogenic Mycobacteria: Contributions to Virulence and Host Immune Suppression, Transboundary and Emerging Diseases, vol.43, issue.6-7, pp.255-68, 2009. ,
DOI : 10.1111/j.1865-1682.2009.01072.x
Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans, Proc Natl Acad Sci U S A, vol.101, pp.1345-1349, 2004. ,
Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer, Genome Res, vol.17, pp.192-200, 2007. ,
virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer, Biochemical Society Transactions, vol.11, issue.1, pp.177-183, 2014. ,
DOI : 10.1002/cbic.200400339
The Angiotensin II Type 2 Receptor for Pain Control, Cell, vol.157, issue.7, pp.1504-1506, 2014. ,
DOI : 10.1016/j.cell.2014.05.030
Highly sensitive, operationally simple, cost/time effective detection of the mycolactones from the human pathogen Mycobacterium ulcerans, Chemical Communications, vol.66, issue.9, pp.1410-1412, 2010. ,
DOI : 10.1039/b924896j
Neutrophil Isolation Protocol, Journal of Visualized Experiments, vol.17, issue.17, 2008. ,
DOI : 10.3791/745
The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats, Pain, vol.4, issue.Supp C, pp.161-174, 1977. ,
DOI : 10.1016/0304-3959(77)90130-0
Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways, Proceedings of the National Academy of Sciences, vol.103, issue.47, pp.17979-17984, 2006. ,
DOI : 10.1073/pnas.0605865103